Cardiac troponin levels are regarded as the most specific of currently avai
lable biochemical markers of myocardial damage. Elevated levels of troponin
have been previously reported in patients with left heart failure, reflect
ing small areas of undetected myocardial cell death. The aim of this study
was to compare the levels of the cardiac troponin I (cTnI) in patients with
left- and right-sided heart failure.
Cardiac troponin I levels were studied with immunochemical methods in patie
nts with right heart failure (n = 17) resulting from chronic obstructive pu
lmonary disease, ischemic left heart failure (n = 23), and nonischemic left
heart failure (n = 18) who were admitted to departments of cardiology and
chest diseases. Also, cTnI levels were measured in 32 healthy subjects as c
ontrol group. Protein markers of myocardial injury (cTnI and myoglobin) in
patients with left and right heart failure were collected approximately 12
to 36 hours after onset of obvious symptoms. Serum creatine kinase MB band
was determined on admission and thereafter twice a day during the first 3 d
ays.
Elevated levels of serum cTnI were found in patients with nonischemic (0.83
+/-0.6 ng/mL, p < 0.01) and ischemic left heart failure (0.9 +/-0.5 ng/mL,
p < 0.01) when compared to healthy subjects, whereas serum cTnI levels in
patients with right heart failure due to chronic obstructive pulmonary dise
ase were not significantly different from those of control subjects (0.22 <
plus/minus>0.1 vs 0.16 +/-0.1 ng/mL, p > 0.05). In addition, creatine kinas
e MB band and myoglobin levels were not significantly different between pat
ient and healthy groups.
The mean of cTnI levels in ischemic and even nonischemic left heart failure
were increased compared to the mean of values in healthy individuals but w
ithout significant creatine kinase MB band and myoglobin elevations. But cT
nI levels were not increased in patients with right heart failure due to ch
ronic obstructive pulmonary disease. These data indicate that the cTnI leve
ls are abnormal in left heart failure but not in cor pulmonale.